Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jan;470(1):187-198.
doi: 10.1007/s00424-017-2044-5. Epub 2017 Aug 19.

Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compounds

Affiliations
Review

Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compounds

Cristobal de Los Rios et al. Pflugers Arch. 2018 Jan.

Abstract

In this review, we show how chromaffin cells have contributed to evaluate neuroprotective compounds with diverse mechanisms of action. Chromaffin cells are considered paraneurons, as they share many common features with neurons: (i) they synthesize, store, and release neurotransmitters upon stimulation and (ii) they express voltage-dependent calcium, sodium, and potassium channels, in addition to a wide variety of receptors. All these characteristics, together with the fact that primary cultures from bovine adrenal glands or chromaffin cells from the tumor pheochromocytoma cell line PC12 are easy to culture, make them an ideal model to study neurotoxic mechanisms and neuroprotective drugs. In the first part of this review, we will analyze the different cytotoxicity models related to calcium dyshomeostasis and neurodegenerative disorders like Alzheimer's or Parkinson's. Along the second part of the review, we describe how different classes of drugs have been evaluated in chromaffin cells to determine their neuroprotective profile in different neurodegenerative-related models.

Keywords: Calcium; Cell death; Chromaffin cells; Neuroprotection; PC12 cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol. 2002 Dec;137(7):993-1000 - PubMed
    1. J Physiol. 1961 Nov;159:40-57 - PubMed
    1. J Biol Chem. 2001 Oct 26;276(43):39695-704 - PubMed
    1. Eur J Pharmacol. 2006 Dec 28;553(1-3):28-38 - PubMed
    1. Brain Res. 2000 Aug 4;873(1):149-54 - PubMed

Publication types

LinkOut - more resources